Hygea Medical Technology Co., Ltd. is a medical device company based in Beijing, China, focused on technologies for minimally invasive tumor treatment. It develops and manufactures cryoablation systems and microwave ablation devices for hospitals and clinics worldwide. The company’s solutions are designed to help physicians treat tumors with precision while supporting patient care and recovery.

A featured offering is the AI Epic series of Co-Ablation Systems. These systems combine ultra-low-temperature cryoablation with a high-intensity hyperthermia function. According to Hygea, the approach supports precise tumor ablation and can help minimize probe-tract bleeding and reduce the risk of tumor seeding metastasis. Its technologies are presented for clinical applications involving lung, bone, liver, and pancreatic cancers.

Hygea describes itself as an innovator in interventional medicine, developing reliable, high-performance devices to expand treatment possibilities and improve patient outcomes. The company also shares clinical cases and product information for healthcare professionals. Its stated reach includes hospitals served and patients treated, reflecting a focus on bringing minimally invasive ablation solutions to clinical settings.